COMPLICATIONS OF POLYPHARMACY IN ELDERLY WITH SYSTEMIC ARTERIAL HYPERTENSION

• DOI: 10.22533/at.ed.1592272205065

• Palavras-chave: Elderly, polypharmacy, hypertension.

• Keywords: Elderly, polypharmacy, hypertension.

• Abstract:

  Polypharmacy is a clinical condition defined by the use of four or more drugs with or without professional guidance (WHO, 2017). Such drugs when prescribed with the best scientific evidence present in the literature based on strong studies, the drugs can bring quality of life and longevity, minimizing possible damage. However, when the harms of medication outweigh the benefits, from unacceptable amounts of drugs or through unnecessary treatments, polymedication must be re-evaluated (PAYNE., 2020). In patients with Systemic Arterial Hypertension, polypharmacy is quite common, since blood pressure control is important to avoid the risk of cardiovascular mortality. Depending on the severity of the SAH, the simultaneous use of more than one class of antihypertensive medication may be necessary. In this sense, this article aims to address the multifactorial character of the recognition and analysis of possible consequences of the use of polypharmacy in patients who have systemic arterial hypertension. For example, the risk to patient safety due to adverse effects and drug interactions.

• Número de páginas: 10